Tilray Brands, Inc. ( TLRY) - Stock Earnings
TLRY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 8, 2026, midnight | — / — | — | — / — | — |
TLRY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -125.8 million USD | 255.6 million USD |
| 2024Q4 | -1.1 billion USD | 268.3 million USD |
| 2025Q4 | -36.3 million USD | 282.2 million USD |
| 2026Q3 Est. | — | — |
TLRY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -333.8 million USD | 1.1 billion USD |
| 2025 | -3.0 billion USD | 1.1 billion USD |
| 2026 | -122.6 million USD | 915.5 million USD |
| 2026 Est. | — | — |
TLRY
Price: $3.94
Earnings Per Share: -1.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 12.7 million
Market Capitalization: 503.2 million